Efficacy Outcomes, W24 ANRS 12 180
{"Image DocumentName": "Efficacy Outcomes, W24 ANRS", "Image ImageDescription": "Primary endpoint : HIV RNA<50 cp/mL at W20 and W24, mITT (M=F, D/C=F) EFV N = 51. RAL 400. N = 51. RAL 800. PRIMARY ENDPOINT. n. % [95% CI] % [95% CI] Success [49-76] [65-88] [67-90] Failure [24-51] [12-35] [10-33] Virologic failure AE leading to treatment discontinuation Death. Withdrawal / Lost to Follow-up. Secondary endpoint : HIV RNA<400 cp/mL at W20 and W24, mITT (M=F, D/C=F) EFV. N = 51. RAL 400. RAL 800. SECONDARY ENDPOINT. n. % [95% CI] Success [65-88] [69-91] [72-93] Failure [12-35] [9-31] [7-28] Virologic failure AE leading to treatment discontinuation. 3. Death. Withdrawal / Lost to Follow-up.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}